Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Shima Mahmoudi & Hossein Keshavarz. (2017) Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan. Human Vaccines & Immunotherapeutics 13:9, pages 2098-2101.
Read now
Read now
Nathalie Garçon & Alberta Di Pasquale. (2017) From discovery to licensure, the Adjuvant System story. Human Vaccines & Immunotherapeutics 13:1, pages 19-33.
Read now
Read now
Kwaku Poku Asante, George Adjei, Yeetey Enuameh & Seth Owusu-Agyei. (2016) RTS,S malaria vaccine development: progress and considerations for postapproval introduction. Vaccine: Development and Therapy 6, pages 25-32.
Read now
Read now
Nathalie Garçon & Marcelle Van Mechelen. (2011) Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems. Expert Review of Vaccines 10:4, pages 471-486.
Read now
Read now
Claudia A Daubenberger. (2010) Gene-expression analysis for prediction of RTS,S-induced protection in humans. Expert Review of Vaccines 9:5, pages 465-469.
Read now
Read now
Katarina Radošević, Ariane Rodriguez, Angelique Lemckert & Jaap Goudsmit. (2009) Heterologous prime–boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Review of Vaccines 8:5, pages 577-592.
Read now
Read now
Nikolai Petrovsky. (2008) Freeing vaccine adjuvants from dangerous immunological dogma. Expert Review of Vaccines 7:1, pages 7-10.
Read now
Read now
Nathalie Garçon, Patrick Chomez & Marcelle Van Mechelen. (2007) GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives. Expert Review of Vaccines 6:5, pages 723-739.
Read now
Read now
Cara K Fraser, Kerrilyn R Diener, Michael P Brown & John D Hayball. (2007) Improving vaccines by incorporating immunological coadjuvants. Expert Review of Vaccines 6:4, pages 559-578.
Read now
Read now
Anne C Moore & Claire L Hutchings. (2007) Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity. Expert Review of Vaccines 6:1, pages 111-121.
Read now
Read now
Kalifa A Bojang. (2006) RTS,S/AS02A for malaria. Expert Review of Vaccines 5:5, pages 611-615.
Read now
Read now
W Ripley Ballou. (2005) Malaria vaccines in development. Expert Opinion on Emerging Drugs 10:3, pages 489-503.
Read now
Read now
Articles from other publishers (74)
Fernando Augusto Siqueira Mathias, Thais Lopes Valentim Di Paschoale Ostolin, Levi Eduardo Soares Reis, Jamille Mirelle de Oliveira Cardoso, Rory Cristiane Fortes De Brito, Rodrigo Dian de Oliveira Aguiar Soares, Bruno Mendes Roatt, Paula Melo de Abreu Vieira & Alexandre Barbosa Reis. (2023) The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection. Vaccines 11:2, pages 395.
Crossref
Crossref
Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong & Tsung-Hsien Chuang. (2022) Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. Pharmaceutics 14:2, pages 423.
Crossref
Crossref
Nouh Saad Mohamed, Hanadi AbdElbagi, Ahad R. Elsadig, Abdalla Elssir Ahmed, Yassir Osman Mohammed, Lubna Taj Elssir, Mohammed-Ahmed B. Elnour, Yousif Ali, Mohamed S. Ali, Omnia Altahir, Mustafa Abubakr, Emmanuel Edwar Siddig, Ayman Ahmed & Rihab Ali Omer. (2021) Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate. Malaria Journal 20:1.
Crossref
Crossref
Shumaila Naz, Sajjad Ahmad, Sumra Wajid Abbasi, Saba Ismail, Shahid Waseem, Muhammad Tahir ul Qamar, Ahmad Almatroudi & Zain Ali. (2021) Identification of immunodominant epitopes in allelic variants VK210 and VK247 of Plasmodium Vivax Circumsporozoite immunogen. Infection, Genetics and Evolution 96, pages 105120.
Crossref
Crossref
Sukanya Patra, Monika Singh, Kirti Wasnik, Divya Pareek, Prem Shankar Gupta, Sudip Mukherjee & Pradip Paik. (2021) Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement. ACS Applied Bio Materials 4:10, pages 7342-7365.
Crossref
Crossref
James E. Moon, Melissa E. Greenleaf, Jason A. Regules, Muriel Debois, Elizabeth H. Duncan, Martha Sedegah, Ilin Chuang, Cynthia K. Lee, April K. Sikaffy, Lindsey S. Garver, Karen Ivinson, Evelina Angov, Danielle Morelle, Marc Lievens, Christian F. Ockenhouse, Viseth Ngauy & Opokua Ofori-Anyinam. (2021) A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge. Vaccine 39:43, pages 6398-6406.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Navid D. Djadid & Akram A. Mehrizi. (2021) A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development. International Journal for Parasitology 51:9, pages 699-717.
Crossref
Crossref
Jessica Molina-Franky, Laura Cuy-Chaparro, Anny Camargo, César Reyes, Marcela Gómez, David Ricardo Salamanca, Manuel Alfonso Patarroyo & Manuel Elkin Patarroyo. (2020) Plasmodium falciparum pre-erythrocytic stage vaccine development. Malaria Journal 19:1.
Crossref
Crossref
James E Moon, Christian Ockenhouse, Jason A Regules, Johan Vekemans, Cynthia Lee, Ilin Chuang, Magali Traskine, Erik Jongert, Karen Ivinson, Danielle Morelle, Jack L Komisar, Marc Lievens, Martha Sedegah, Lindsey S Garver, April K Sikaffy, Norman C Waters, William Ripley Ballou, Opokua Ofori-Anyinam, Susan B Cicatelli, Elizabeth H Duncan, Kristin T Mills, Christine E Lee, Judith E Epstein, Jessica J Cowden, Michele D Spring, Melinda J Hamer, Nathanial K Copeland, Viseth Ngauy, Donna M Tosh, Justin M Curley, Jason W Bennett, Mark Riddle, Paige E Waterman, Michael A Koren, Jack N Hutter, Elke Bergmann-Leitner, Jennifer Kooken, Evelina Angov, Kyle Peterson, Aurélia Leprince, Linda Murray, Susan B Cicatelli, Elizabeth H Duncan, Kristin T Mills, Christine E Lee, Judith E Epstein, Jessica J Cowden, Michele D Spring, Melinda J Hamer, Nathanial K Copeland, Viseth Ngauy, Donna M Tosh, Justin M Curley, Jason W Bennett, Mark Riddle, Paige E Waterman, Michael A Koren, Jack N Hutter, Elke Bergmann-Leitner, Jennifer Kooken, Evelina Angov, Kyle Peterson, Aurélia Leprince & Linda Murray. (2020) A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults. The Journal of Infectious Diseases 222:10, pages 1681-1691.
Crossref
Crossref
Isabela Ferreira Soares, César López-Camacho, Rodrigo Nunes Rodrigues-da-Silva, Ada da Silva Matos, Barbara de Oliveira Baptista, Paulo Renato Rivas Totino, Rodrigo Medeiros de Souza, Kate Harrison, Alba Marina Gimenez, Elisângela Oliveira de Freitas, Young Chan Kim, Joseli Oliveira-Ferreira, Cláudio Tadeu Daniel-Ribeiro, Arturo Reyes-Sandoval, Lilian Rose Pratt-Riccio & Josué da Costa Lima-Junior. (2020) Recombinant Plasmodium vivax circumsporozoite surface protein allelic variants: antibody recognition by individuals from three communities in the Brazilian Amazon. Scientific Reports 10:1.
Crossref
Crossref
Mariusz Skwarczynski, Saranya Chandrudu, Berta Rigau-Planella, Md. Tanjir Islam, Yee S. Cheong, Genan Liu, Xiumin Wang, Istvan Toth & Waleed M. Hussein. (2020) Progress in the Development of Subunit Vaccines against Malaria. Vaccines 8:3, pages 373.
Crossref
Crossref
Monica L. Martin, Alexis A. Bitzer, Andrew Schrader, Elke S. Bergmann-Leitner, Kim Soto, Xiaoyan Zou, Zoltan Beck, Gary R. Matyas & Sheetij Dutta. (2019) Comparison of immunogenicity and safety outcomes of a malaria vaccine FMP013/ALFQ in rhesus macaques (Macaca mulatta) of Indian and Chinese origin. Malaria Journal 18:1.
Crossref
Crossref
Nouh S. Mohamed, Musab M. Ali Albsheer, Hanadi Abdelbagi, Emanuel E. Siddig, Mona A. Mohamed, Abdallah E. Ahmed, Rihab Ali Omer, Mohamed S. Muneer, Ayman Ahmed, Hussam A. Osman, Mohamed S. Ali, Ibrahim M. Eisa & Mohamed M. Elbasheir. (2019) Genetic polymorphism of the N-terminal region in circumsporozoite surface protein of Plasmodium falciparum field isolates from Sudan. Malaria Journal 18:1.
Crossref
Crossref
Daniel G.W. Alanine, Doris Quinkert, Rasika Kumarasingha, Shahid Mehmood, Francesca R. Donnellan, Nana K. Minkah, Bernadeta Dadonaite, Ababacar Diouf, Francis Galaway, Sarah E. Silk, Abhishek Jamwal, Jennifer M. Marshall, Kazutoyo Miura, Lander Foquet, Sean C. Elias, Geneviève M. Labbé, Alexander D. Douglas, Jing Jin, Ruth O. Payne, Joseph J. Illingworth, David J. Pattinson, David Pulido, Barnabas G. Williams, Willem A. de Jongh, Gavin J. Wright, Stefan H.I. Kappe, Carol V. Robinson, Carole A. Long, Brendan S. Crabb, Paul R. Gilson, Matthew K. Higgins & Simon J. Draper. (2019) Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies. Cell 178:1, pages 216-228.e21.
Crossref
Crossref
Hương Giang Lê, Jung-Mi Kang, Mya Moe, Hojong Jun, Thị Lam Thái, Jinyoung Lee, Moe Kyaw Myint, Khin Lin, Woon-Mok Sohn, Ho-Joon Shin, Tong-Soo Kim & Byoung-Kuk Na. (2018) Genetic polymorphism and natural selection of circumsporozoite surface protein in Plasmodium falciparum field isolates from Myanmar. Malaria Journal 17:1.
Crossref
Crossref
Hao Li & Babak Javid. (2018) Antibodies and tuberculosis: finally coming of age?. Nature Reviews Immunology 18:9, pages 591-596.
Crossref
Crossref
Jing Jin, Richard D. Tarrant, Emma J. Bolam, Philip Angell-Manning, Max Soegaard, David J. Pattinson, Pawan Dulal, Sarah E. Silk, Jennifer M. Marshall, Rebecca A. Dabbs, Fay L. Nugent, Jordan R. Barrett, Kathryn A. Hjerrild, Lars Poulsen, Thomas Jørgensen, Tanja Brenner, Ioana N. Baleanu, Helena M. Parracho, Abdessamad Tahiri-Alaoui, Gary Whale, Sarah Moyle, Ruth O. Payne, Angela M. Minassian, Matthew K. Higgins, Frank J. Detmers, Alison M. Lawrie, Alexander D. Douglas, Robert Smith, Willem A. de Jongh, Eleanor Berrie, Rebecca Ashfield & Simon J. Draper. (2018) Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells. npj Vaccines 3:1.
Crossref
Crossref
Tarsila Mendes de Camargo, Elisângela Oliveira de Freitas, Alba Marina Gimenez, Luciana Chagas Lima, Karina de Almeida Caramico, Kátia Sanches Françoso, Oscar Bruna-Romero, Chiara Andolina, François Nosten, Laurent Rénia, Hildegund C. J. Ertl, Ruth S. Nussenzweig, Victor Nussenzweig, Mauricio M. Rodrigues, Arturo Reyes-Sandoval & Irene S. Soares. (2018) Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge. Scientific Reports 8:1.
Crossref
Crossref
Takayuki Shiratsuchi, Urvashi Rai, Izumi Kaneko, Min Zhang, Shiroh Iwanaga, Masao Yuda & Moriya Tsuji. (2017) A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII. Vaccine 35:50, pages 6990-7000.
Crossref
Crossref
Munir Akkaya, Billur Akkaya, Patrick W. Sheehan, Pietro Miozzo, Mirna Pena, Chen-Feng Qi, Javier Manzella-Lapeira, Silvia Bolland & Susan K. Pierce. (2017) T cell-dependent antigen adjuvanted with DOTAP-CpG-B but not DOTAP-CpG-A induces robust germinal center responses and high affinity antibodies in mice. European Journal of Immunology 47:11, pages 1890-1899.
Crossref
Crossref
Ahmed M. Salman, Eduardo Montoya-Díaz, Heather West, Amar Lall, Erwan Atcheson, Cesar Lopez-Camacho, Jai Ramesar, Karolis Bauza, Katharine A. Collins, Florian Brod, Fernando Reis, Leontios Pappas, Lilia González-Cerón, Chris J. Janse, Adrian V. S. Hill, Shahid M. Khan & Arturo Reyes-Sandoval. (2017) Rational development of a protective P. vivax vaccine evaluated with transgenic rodent parasite challenge models. Scientific Reports 7:1.
Crossref
Crossref
Shima Mahmoudi & Hossein Keshavarz. (2017) Efficacy of Phase 3 Trial of RTS, S/AS01 Malaria Vaccine in infants: a systematic review and meta-analysis. Human Vaccines & Immunotherapeutics, pages 00-00.
Crossref
Crossref
Shawna F. Graves, Bourema Kouriba, Issa Diarra, Modibo Daou, Amadou Niangaly, Drissa Coulibaly, Yamoussa Keita, Matthew B. Laurens, Andrea A. Berry, Johan Vekemans, W. Ripley Ballou, David E. Lanar, Sheetij Dutta, D. Gray Heppner, Lorraine Soisson, Carter L. Diggs, Mahamadou A. Thera, Ogobara K. Doumbo, Christopher V. Plowe, Marcelo B. Sztein & Kirsten E. Lyke. (2016) Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine 34:23, pages 2546-2555.
Crossref
Crossref
Sathit Pichyangkul, Kosol Yongvanitchit, Amporn Limsalakpetch, Utaiwan Kum-Arb, Rawiwan Im-Erbsin, Kobporn Boonnak, Arunee Thitithayanont, Anan Jongkaewwattana, Suwimon Wiboon-ut, Duangrat Mongkolsirichaikul, Rangsini Mahanonda, Michele Spring, Ilin Chuang, Carl J. Mason & David L. Saunders. (2015) Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection. The Journal of Immunology 195:9, pages 4378-4386.
Crossref
Crossref
Marcela Parra, Xia Liu, Steven C. Derrick, Amy Yang, Alvaro Molina-Cruz, Carolina Barillas-Mury, Hong Zheng, Phuong Thao Pham, Martha Sedegah, Arnel Belmonte, Dianne D. Litilit, Thomas A. Waldmann, Sanjai Kumar, Sheldon L. Morris & Liyanage P. Perera. (2015) Co-expression of Interleukin-15 Enhances the Protective Immune Responses Induced by Immunization with a Murine Malaria MVA-Based Vaccine Encoding the Circumsporozoite Protein. PLOS ONE 10:10, pages e0141141.
Crossref
Crossref
Sibel Durlanik & Andreas Thiel. (2015) Requirement of immune system heterogeneity for protective immunity. Vaccine 33:40, pages 5308-5312.
Crossref
Crossref
Christian F. Ockenhouse, Jason Regules, Donna Tosh, Jessica Cowden, April Kathcart, James Cummings, Kristopher Paolino, James Moon, Jack Komisar, Edwin Kamau, Thomas Oliver, Austin Chhoeu, Jitta Murphy, Kirsten Lyke, Matthew Laurens, Ashley Birkett, Cynthia Lee, Rich Weltzin, Ulrike Wille-Reece, Martha Sedegah, Jenny Hendriks, Isabella Versteege, Maria Grazia Pau, Jerold Sadoff, Yannick Vanloubbeeck, Marc Lievens, Dirk Heerwegh, Philippe Moris, Yolanda Guerra Mendoza, Erik Jongert, Joe Cohen, Gerald Voss, W. Ripley Ballou & Johan Vekemans. (2015) Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults. PLOS ONE 10:7, pages e0131571.
Crossref
Crossref
Bert A. ׳t Hart, Willy M. Bogers, Krista G. Haanstra, Frank A. Verreck & Clemens H. Kocken. (2015) The translational value of non-human primates in preclinical research on infection and immunopathology. European Journal of Pharmacology 759, pages 69-83.
Crossref
Crossref
Lawrence Segal, Danielle Morelle, Mark Blee, Emma Moore, Micaela Damsten, Kai Chiu Liu, Eric Destexhe & Nathalie Garçon. (2015) Local tolerance and systemic toxicity of single and repeated intramuscular administrations of two different formulations of the RTS,S malaria candidate vaccine in rabbits. Regulatory Toxicology and Pharmacology 71:2, pages 269-278.
Crossref
Crossref
Geert Leroux-Roels, Pascale Van Belle, Pierre Vandepapeliere, Yves Horsmans, Michel Janssens, Isabelle Carletti, Nathalie Garçon, Martine Wettendorff & Marcelle Van Mechelen. (2015) Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination. Vaccine 33:8, pages 1084-1091.
Crossref
Crossref
E. Destexhe, D. Stannard, O.K. Wilby, E. Grosdidier, N. Baudson, R. Forster, C.M. Gérard, N. Garçon & L. Segal. (2015) Nonclinical reproductive and developmental safety evaluation of the MAGE-A3 Cancer Immunotherapeutic, a therapeutic vaccine for cancer treatment. Reproductive Toxicology 51, pages 90-105.
Crossref
Crossref
Kent E. Kester, D. Gray HeppnerJrJr, Philippe Moris, Opokua Ofori-Anyinam, Urszula Krzych, Nadia Tornieporth, Denise McKinney, Martine Delchambre, Christian F. Ockenhouse, Gerald Voss, Carolyn Holland, Jolie Palensky Beckey, W. Ripley Ballou & Joe Cohen. (2014) Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults. Vaccine 32:49, pages 6683-6691.
Crossref
Crossref
Catherine Gérard, Nathalie Baudson, Thierry Ory & Jamila Louahed. (2014) Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses. PLoS ONE 9:5, pages e94883.
Crossref
Crossref
Benoît Levast, Sunita Awate, Lorne Babiuk, George Mutwiri, Volker Gerdts & Sylvia van Drunen Littel-van den Hurk. (2014) Vaccine Potentiation by Combination Adjuvants. Vaccines 2:2, pages 297-322.
Crossref
Crossref
Shyamapada Mandal. (2014) Epidemiological aspects of vivax and falciparum malaria: global spectrum. Asian Pacific Journal of Tropical Disease 4, pages S13-S26.
Crossref
Crossref
Jann Hau & Steven SchapiroIdle Farah, Maina Ngotho, John Kagira, Thomas Kariuki, Maamun Jeneby, Naomi Maina, Michael Gicheru, Hastings Ozwara & Jann Hau. 2013. Handbook of Laboratory Animal Science, Volume III, Third Edition. Handbook of Laboratory Animal Science, Volume III, Third Edition
43
106
.
Mitsuhiro Iyori, Hiroki Nakaya, Katsuya Inagaki, Sathit Pichyangkul, Daisuke S. Yamamoto, Masanori Kawasaki, Kyungtak Kwak, Masami Mizukoshi, Yoshihiro Goto, Hiroyuki Matsuoka, Makoto Matsumoto & Shigeto Yoshida. (2013) Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite Protein. PLoS ONE 8:8, pages e70819.
Crossref
Crossref
Janny Westdijk, Patrick Koedam, Mario Barro, Benjamin P. Steil, Nicolas Collin, Thomas S. Vedvick, Wilfried A.M. Bakker, Peter van der Ley & Gideon Kersten. (2013) Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains. Vaccine 31:9, pages 1298-1304.
Crossref
Crossref
Robert Schwenk, Joanne M. Lumsden, Lisa E. Rein, Laure Juompan, Kent E. Kester, D. Gray Heppner & Urszula Krzych. (2011) Immunization with the RTS,S/AS malaria vaccine induces IFN-γ+CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge. Vaccine 29:48, pages 8847-8854.
Crossref
Crossref
Joanne M. Lumsden, Sathit Pichyangkul, Utaiwan Srichairatanakul, Kosol Yongvanitchit, Amporn Limsalakpetch, Saule Nurmukhambetova, Jennifer Klein, Sylvie Bertholet, Thomas S. Vedvick, Steven G. Reed, Jetsumon Sattabongkot, Jason W. Bennett, Mark E. Polhemus, Christian F. Ockenhouse, Randall F. Howard & Anjali Yadava. (2011) Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an Emulsion. Infection and Immunity 79:9, pages 3492-3500.
Crossref
Crossref
Joanne M. Lumsden, Robert J. Schwenk, Lisa E. Rein, Philippe Moris, Michel Janssens, Opokua Ofori-Anyinam, Joe Cohen, Kent E. Kester, D. Gray Heppner & Urszula Krzych. (2011) Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells. PLoS ONE 6:7, pages e20775.
Crossref
Crossref
Philip Bejon, Jackie Cook, Elke Bergmann-Leitner, Ally Olotu, John Lusingu, Jedidah Mwacharo, Johan Vekemans, Patricia Njuguna, Amanda Leach, Marc Lievens, Sheetij Dutta, Lorenz von Seidlein, Barbara Savarese, Tonya Villafana, Martha M. Lemnge, Joe Cohen, Kevin Marsh, Patrick H. Corran, Evelina Angov, Eleanor M. Riley & Chris J. Drakeley. (2011) Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01E on Blood Stage Immunity in Young Children. The Journal of Infectious Diseases 204:1, pages 9-18.
Crossref
Crossref
Daniel Ansong, Kwaku P. Asante, Johan Vekemans, Sandra K. Owusu, Ruth Owusu, Naana A. W. Brobby, David Dosoo, Alex Osei-Akoto, Kingsley Osei-Kwakye, Emmanuel Asafo-Adjei, Kwadwo O. Boahen, Justice Sylverken, George Adjei, David Sambian, Stephen Apanga, Kingsley Kayan, Michel H. Janssens, Marc J. J. Lievens, Aurelie C. Olivier, Erik Jongert, Patrice Dubois, Barbara M. Savarese, Joe Cohen, Sampson Antwi, Brian M. Greenwood, Jennifer A. Evans, Tsiri Agbenyega, Philippe J. Moris & Seth Owusu-Agyei. (2011) T Cell Responses to the RTS,S/AS01E and RTS,S/AS02D Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children. PLoS ONE 6:4, pages e18891.
Crossref
Crossref
Selidji T. Agnandji, Rolf Fendel, Michaël Mestré, Michel Janssens, Johan Vekemans, Jana Held, Ferdinand Gnansounou, Sonja Haertle, Isabel von Glasenapp, Sunny Oyakhirome, Ludovic Mewono, Philippe Moris, Marc Lievens, Marie-Ange Demoitie, Patrice M. Dubois, Tonya Villafana, Erik Jongert, Aurelie Olivier, Joe Cohen, Meral Esen, Peter G. Kremsner, Bertrand Lell & Benjamin Mordmüller. (2011) Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D. PLoS ONE 6:4, pages e18559.
Crossref
Crossref
Joe Cohen, Sarah Benns, Johan Vekemans, Amanda Leach & Lode Schuerman. 2011. Progress in Parasitology. Progress in Parasitology
121
133
.
J. Cohen, S. Benns, J. Vekemans & A. Leach. (2010) Le candidat vaccin antipaludique RTS,S/AS est entré en essais cliniques de phase III. Annales Pharmaceutiques Françaises 68:6, pages 370-379.
Crossref
Crossref
Anjeanette RobertsElaine W. LamirandeLeatrice VogelBenoît BarasGeneviève GoossensIsabelle KnottJun ChenJerrold M. WardVentzislav VassilevKanta Subbarao. (2010) Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine. Viral Immunology 23:5, pages 509-519.
Crossref
Crossref
Geert Leroux-Roels. (2010) Unmet needs in modern vaccinology. Vaccine 28, pages C25-C36.
Crossref
Crossref
Lin H. Chen. (2010) Clinical Trials Report: Progress Toward an Effective Malaria Vaccine: RTS,S/ASO1B and RTS,S/ASO2A. Current Infectious Disease Reports 12:3, pages 155-156.
Crossref
Crossref
Shayne Cox GadA. Marguerite Dempster & Richard Haworth. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Vasee S Moorthy & Marie Paule Kieny. (2010) Reducing empiricism in malaria vaccine design. The Lancet Infectious Diseases 10:3, pages 204-211.
Crossref
Crossref
Gustavo Bracho, Caridad Zayas, Lina Wang, Ross Coppel, Oliver Pérez & Nikolai Petrovsky. (2009) AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5. Malaria Journal 8:1.
Crossref
Crossref
Vasee S Moorthy & W Ripley Ballou. (2009) Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malaria Journal 8:1.
Crossref
Crossref
S. Pichyangkul, P. Tongtawe, U. Kum-Arb, K. Yongvanitchit, M. Gettayacamin, M.R. Hollingdale, A. Limsalakpetch, V.A. Stewart, D.E. Lanar, S. Dutta, E. Angov, L.A. Ware, E.S. Bergmann-Leitner, B. House, G. Voss, M.C. Dubois, J.D. Cohen, M.M. Fukuda, D.G. Heppner & R.S. Miller. (2009) Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys. Vaccine 28:2, pages 452-462.
Crossref
Crossref
W. R. BALLOU. (2009) The development of the RTS,S malaria vaccine candidate: challenges and lessons. Parasite Immunology 31:9, pages 492-500.
Crossref
Crossref
Mark E. Polhemus, Shon A. Remich, Bernhards R. Ogutu, John N. Waitumbi, Lucas Otieno, Stella Apollo, James F. Cummings, Kent E. Kester, Christian F. Ockenhouse, Ann Stewart, Opokua Ofori-Anyinam, Isabelle Ramboer, Conor P. Cahill, Marc Lievens, Marie-Claude Dubois, Marie-Ange Demoitie, Amanda Leach, Joe Cohen, W. Ripley Ballou & D. Gray Heppner. (2009) Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area. PLoS ONE 4:7, pages e6465.
Crossref
Crossref
Stella M Chenet, OraLee H Branch, Ananias A Escalante, Carmen M Lucas & David J Bacon. (2008) Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Malaria Journal 7:1.
Crossref
Crossref
Joseph P. Shott, Shannon M. McGrath, Maria Grazia Pau, Jerome H.V. Custers, Olga Ophorst, Marie-Ange Demoitié, Marie-Claude Dubois, Jack Komisar, Michelle Cobb, Kent E. Kester, Patrice Dubois, Joe Cohen, Jaap Goudsmit, D. Gray Heppner & V. Ann Stewart. (2008) Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in mice. Vaccine 26:23, pages 2818-2823.
Crossref
Crossref
Kent E. Kester, James F. Cummings, Christian F. Ockenhouse, Robin Nielsen, B. Ted Hall, Daniel M. Gordon, Robert J. Schwenk, Urszula Krzych, Carolyn A. Holland, Gregory Richmond, Megan G. Dowler, Jackie Williams, Robert A. Wirtz, Nadia Tornieporth, Laurence Vigneron, Martine Delchambre, Marie-Ange Demoitie, W. Ripley Ballou, Joe Cohen & D. Gray HeppnerJr.Jr.. (2008) Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research. Vaccine 26:18, pages 2191-2202.
Crossref
Crossref
Pierre Vandepapelière, Yves Horsmans, Philippe Moris, Marcelle Van Mechelen, Michel Janssens, Marguerite Koutsoukos, Pascale Van Belle, Frédéric Clement, Emmanuel Hanon, Martine Wettendorff, Nathalie Garçon & Geert Leroux-Roels. (2008) Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 26:10, pages 1375-1386.
Crossref
Crossref
Pascal Mettens, Patrice M. Dubois, Marie-Ange Demoitié, Babak Bayat, Marie-Noëlle Donner, Patricia Bourguignon, V. Ann Stewart, D. Gray HeppnerJr.Jr., Nathalie Garçon & Joe Cohen. (2008) Improved T cell responses to Plasmodium falciparum circumsporozoite protein in mice and monkeys induced by a novel formulation of RTS,S vaccine antigen. Vaccine 26:8, pages 1072-1082.
Crossref
Crossref
S. Pichyangkul, U. Kum-Arb, K. Yongvanitchit, A. Limsalakpetch, M. Gettayacamin, D. E. Lanar, L. A. Ware, V. A. Stewart, D. G. Heppner, P. Mettens, J. D. Cohen, W. R. Ballou & M. M. Fukuda. (2008)
Preclinical Evaluation of the Safety and Immunogenicity of a Vaccine Consisting of
Plasmodium falciparum
Liver-Stage Antigen 1 with Adjuvant AS01B Administered Alone or Concurrently with the RTS,S/AS01B Vaccine in Rhesus Primates
. Infection and Immunity 76:1, pages 229-238.
Crossref
Crossref
Pierre Druilhe & John W Barnwell. (2007) Pre-erythrocytic stage malaria vaccines: time for a change in path. Current Opinion in Microbiology 10:4, pages 371-378.
Crossref
Crossref
Bruno Guy. (2007) The perfect mix: recent progress in adjuvant research. Nature Reviews Microbiology 5:7, pages 396-397.
Crossref
Crossref
V. Ann Stewart, Shannon M. McGrath, Patrice M. Dubois, Maria G. Pau, Pascal Mettens, Joseph Shott, Michelle Cobb, J. Robert Burge, David Larson, Lisa A. Ware, Marie-Ange Demoitie, Gerrit Jan Weverling, Babak Bayat, Jerome H. H. V. Custers, Marie-Claude Dubois, Joe Cohen, Jaap Goudsmit & D. Gray HeppnerJr.Jr.. (2007)
Priming with an Adenovirus 35-Circumsporozoite Protein (CS) Vaccine followed by RTS,S/AS01B Boosting Significantly Improves Immunogenicity to
Plasmodium falciparum
CS Compared to That with Either Malaria Vaccine Alone
. Infection and Immunity 75:5, pages 2283-2290.
Crossref
Crossref
Mark E. Polhemus, Alan J. Magill, James F. Cummings, Kent E. Kester, Chris F. Ockenhouse, David E. Lanar, Sheetij Dutta, Arnoldo Barbosa, Lorraine Soisson, Carter L. Diggs, Sally A. Robinson, John D. Haynes, V. Ann Stewart, Lisa A. Ware, Clara Brando, Urszula Krzych, Robert A. Bowden, Joe D. Cohen, Marie-Claude Dubois, Opokua Ofori-Anyinam, Els De-Kock, W. Ripley Ballou & D. Gray HeppnerJr.Jr.. (2007) Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research. Vaccine 25:21, pages 4203-4212.
Crossref
Crossref
V. Ann Stewart, Douglas S. Walsh, Shannon M. McGrath, Kent E. Kester, James F. Cummings, Gerald Voss, Martine Delchambre, Nathalie Garçon, Joe D. Cohen & D. Gray HeppnerJr.Jr.. (2006) Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques. Vaccine 24:42-43, pages 6493-6502.
Crossref
Crossref
V. Ann Stewart, Shannon M. McGrath, Douglas S. Walsh, Stacey Davis, Aaron S. Hess, Lisa A. Ware, Kent E. Kester, James F. Cummings, J. Robert Burge, Gerald Voss, Martine Delchambre, Nathalie Garçon, Douglas B. Tang, Joe D. Cohen & D. Gray HeppnerJr.Jr.. (2006) Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A. Vaccine 24:42-43, pages 6483-6492.
Crossref
Crossref
GERRY F. KILLEEN, NICOLAS MAIRE, THOMAS SMITH, KLAUS DIETZ, LOUIS MOLINEAUX, PENELOPE VOUNATSOU & MARCEL TANNER. (2006) RELATIONSHIP BETWEEN THE ENTOMOLOGIC INOCULATION RATE AND THE FORCE OF INFECTION FOR PLASMODIUM FALCIPARUM MALARIA. The American Journal of Tropical Medicine and Hygiene 75:2_suppl, pages 11-18.
Crossref
Crossref
Charlotte Read Kensil. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
109
122
.
Marcus A. Horwitz, Günter Harth, Barbara Jane Dillon & Saša Masleša-Galić. (2005)
Enhancing the Protective Efficacy of
Mycobacterium bovis
BCG Vaccination against Tuberculosis by Boosting with the
Mycobacterium tuberculosis
Major Secretory Protein
. Infection and Immunity 73:8, pages 4676-4683.
Crossref
Crossref
Jan A.M. Langermans, T. Mark Doherty, Richard A.W. Vervenne, Tridia van der Laan, Konstantin Lyashchenko, Rena Greenwald, Else Marie Agger, Claus Aagaard, Horst Weiler, Dick van Soolingen, Wilfried Dalemans, Alan W. Thomas & Peter Andersen. (2005) Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23:21, pages 2740-2750.
Crossref
Crossref
Pierre Vandepapelière, Barbara Rehermann, Marguerite Koutsoukos, Philippe Moris, Nathalie Garçon, Martine Wettendorff & Geert Leroux-Roels. (2005) Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults. Vaccine 23:20, pages 2591-2601.
Crossref
Crossref
Idle Farah, Maina Ngotho, Thomas Kariuki, Maamun Jeneby, Lawrence Irura, Naomi Maina, John Kagira, Michael Gicheru & Jann Hau. 2004. Handbook of Laboratory Animal Science, Second Edition. Handbook of Laboratory Animal Science, Second Edition
169
223
.